the 6th Rare & Genetic Kidney Disease Drug Development Summit 2026

 

The 6th Rare & Genetic Kidney Disease Drug Development Summit brings together leading experts from biopharma and academia to accelerate therapeutic innovation across rare and inherited renal disorders.

Taking place August 18–20, 2026 in Boston, this industry‑dedicated forum spans discovery through commercialization, highlighting advances in surrogate endpoint validation, targeted modalities, omics‑driven patient stratification, and patient‑centric clinical development.

With growing investment, multiple recent approvals, and heightened competition in IgAN, FSGS, PKD, Alport Syndrome, and C3G, the summit provides an essential platform to share emerging insights, overcome shared challenges, and shape the future of rare kidney drug development.

 

More Info

---

---